Attached files
| file | filename |
|---|---|
| S-1 - REGISTRATION STATEMENT - AzurRx BioPharma, Inc. | azrxs1_dec2019.htm |
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM
We hereby consent to the incorporation by reference in this Form
S-1 constituting part of the Registration Statement on Form S-1 of
our report dated April 1, 2019, related to the consolidated
financial statements of AzurRx BioPharma, Inc. as of December 31,
2018 and 2017 and for the years then ended, which appears in the
Annual Report on Form 10-K of AzurRx BioPharma, Inc. for the year
ended December 31, 2018. The report for AzurRx BioPharma, Inc.
includes an explanatory paragraph about the existence of
substantial doubt concerning its ability to continue as a going
concern. We also consent to the reference to our Firm under the
caption “Experts” in this Form S-1.
/s/ Mazars USA LLP
New York, New York
December 31, 2019